BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vilar‐ribó L, Sánchez‐mora C, Rovira P, Richarte V, Corrales M, Fadeuilhe C, Arribas L, Casas M, Ramos‐quiroga JA, Ribasés M, Soler Artigas M. Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder. Am J Med Genet 2021;186:140-50. [DOI: 10.1002/ajmg.b.32827] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 da Silva BS, Grevet EH, Silva LCF, Ramos JKN, Rovaris DL, Bau CHD. An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder. Discov Ment Health 2023;3:2. [DOI: 10.1007/s44192-022-00030-1] [Reference Citation Analysis]
2 Yates JR. Individual differences in addiction. Determinants of Addiction 2023. [DOI: 10.1016/b978-0-323-90578-7.00013-x] [Reference Citation Analysis]
3 Riglin L, Stergiakouli E. Mendelian randomisation studies of Attention Deficit Hyperactivity Disorder. JCPP Advances 2022. [DOI: 10.1002/jcv2.12117] [Reference Citation Analysis]
4 Saccaro LF, Gasparini S, Rutigliano G. Applications of Mendelian randomization in psychiatry: a comprehensive systematic review. Psychiatr Genet 2022;32:199-213. [PMID: 36354137 DOI: 10.1097/YPG.0000000000000327] [Reference Citation Analysis]
5 Høj Jørgensen TS, Osler M, Jorgensen MB, Jorgensen A. Mapping diagnostic trajectories from the first hospital diagnosis of a psychiatric disorder: a Danish nationwide cohort study using sequence analysis. The Lancet Psychiatry 2022. [DOI: 10.1016/s2215-0366(22)00367-4] [Reference Citation Analysis]
6 Badrfam R, Zandifar A, Barkhori Mehni M, Farid M, Rahiminejad F. Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran. BMC Psychiatry 2022;22:480. [PMID: 35854247 DOI: 10.1186/s12888-022-04124-6] [Reference Citation Analysis]
7 Niarchou M, Sealock JM, Straub P, Sanchez-Roige S, Sutcliffe JS, Davis LK. A phenome-wide association study of polygenic scores for attention deficit hyperactivity disorder across two genetic ancestries in electronic health record data. Am J Med Genet B Neuropsychiatr Genet 2022. [PMID: 35841203 DOI: 10.1002/ajmg.b.32911] [Reference Citation Analysis]
8 Soler Artigas M, Sánchez-Mora C, Rovira P, Vilar-Ribó L, Ramos-Quiroga JA, Ribasés M. Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes. Int J Epidemiol 2022:dyac128. [PMID: 35690959 DOI: 10.1093/ije/dyac128] [Reference Citation Analysis]
9 Haan E, Westmoreland KE, Schellhas L, Sallis HM, Taylor G, Zuccolo L, Munafò MR. Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta-analysis. Addiction 2022. [PMID: 35385887 DOI: 10.1111/add.15858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ivanov I, Bjork JM, Blair J, Newcorn JH. Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence. Neurosci Biobehav Rev 2022;135:104575. [PMID: 35151770 DOI: 10.1016/j.neubiorev.2022.104575] [Reference Citation Analysis]
11 Paraskevopoulou M, van Rooij D, Schene AH, Batalla A, Chauvin RJ, Buitelaar JK, Schellekens AFA. Effects of family history of substance use disorder on reward processing in adolescents with and without attention-deficit/hyperactivity disorder. Addict Biol 2022;27:e13137. [PMID: 35229951 DOI: 10.1111/adb.13137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Al-Soufi L, Martorell L, Moltó MD, González-Peñas J, García-Portilla MP, Arrojo M, Rivero O, Gutiérrez-Zotes A, Nácher J, Muntané G, Paz E, Páramo M, Bobes J, Arango C, Sanjuan J, Vilella E, Costas J. A polygenic approach to the association between smoking and schizophrenia. Addict Biol 2022;27:e13104. [PMID: 34779080 DOI: 10.1111/adb.13104] [Reference Citation Analysis]
13 Naya N, Tsuji T, Nishigaki N, Sakai C, Chen Y, Jung S, Kosaka H. The Burden of Undiagnosed Adults With Attention-Deficit/Hyperactivity Disorder Symptoms in Japan: A Cross-Sectional Study. Cureus 2021;13:e19615. [PMID: 34956750 DOI: 10.7759/cureus.19615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Haan E, Westmoreland KE, Schellhas L, Sallis HM, Taylor G, Zuccolo L, Munafò MR. Prenatal smoking, alcohol and caffeine exposure and offspring externalising disorders: A systematic review and meta-analysis.. [DOI: 10.1101/2021.06.02.21258212] [Reference Citation Analysis]
15 Cormand B, Cabana-Domínguez J, Forero DA, Fernàndez-Castillo N. Genomics and epigenomics of substance use disorders: An introduction. Am J Med Genet B Neuropsychiatr Genet 2021;186:125-7. [PMID: 33973715 DOI: 10.1002/ajmg.b.32844] [Reference Citation Analysis]